Related Experiment Videos

Protein kinase CK2 interacts with a multi-protein binding domain of p53

C Götz1, P Scholtes, A Prowald

  • 1Medical Biochemistry, University of the Saarland, Homburg, Germany.

Insights

The tumor suppressor p53 interacts with protein kinase CK2. Researchers mapped CK2 binding to p53

Area of Science:

  • Molecular Biology
  • Cellular Regulation
  • Cancer Research

Background:

  • p53 is a critical negative regulator of cell growth.
  • p53 interacts with various cellular proteins, primarily through its N- and C-terminal domains.
  • Protein kinase CK2 is implicated in cellular proliferation processes.

Purpose of the Study:

  • To investigate the binding interaction between p53 and protein kinase CK2.
  • To identify the specific domains of p53 involved in CK2 binding.
  • To determine the role of CK2 subunits in this interaction.

Main Methods:

  • Overlay assays were employed to analyze protein-protein interactions.
  • N- and C-terminal domains of p53 were studied separately.
  • Specific amino acid sequences within p53 were analyzed for binding sites.

Main Results:

  • The binding site for protein kinase CK2 was mapped to amino acids 325-344 in the C-terminal domain of p53.
  • This identified region overlaps with interaction domains of other p53-binding proteins.
  • The regulatory beta-subunit of CK2 binds to the p53 C-terminal domain independently of the catalytic alpha-subunit.

Conclusions:

  • The C-terminal domain of p53 is a key interaction site for protein kinase CK2.
  • CK2's interaction with p53 may be crucial for regulating proliferation.
  • The beta-subunit of CK2 plays a significant role in binding to p53.

Related Concept Videos